Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps
- Guess?, Inc. (GES) Misses Q2 EPS by 3c; Cuts FY15 Outlook
- Apple (AAPL) Could Deliver BIG at September Event with iWatch and 2 iPhone Models
- Williams-Sonoma, Inc. (WSM) Reports In-Line Q2 EPS; Guides FY14 EPS Below Expectations
- UPDATE: FBI Probing Russia Ties to JPMorgan (JPM) Hacking - Bloomberg
- Lannett (LCI) Tops Q4 EPS by 10c; Guides FY15 Revs Above Expectations
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.
You May Also Be Interested In
- Ebola Vaccine Tests to Begin Next Week - U.S. (TKMR) (NLNK) (BCRX)
- BioDelivery Sciences (BDSI) Picking Up Interest Ahead of Next Week's Analyst Day - Summer Street
- UPDATE: FireEye (FEYE) Ramps to Session Highs on Volume; Takeover Chatter Grows Louder
Create E-mail Alert Related CategoriesFDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!